Abbott Laboratorios S.A.

HIV/AIDS and Abbott Abbott is fighting HIV/AIDS all over the world by expanding access to treatment, supporting children and strengthening health care systems. about this important work. News Features Investor's Business Daily provides a unique profile of the physician who started a storefront business that would become a global healthcare company. Based on a growing body of scientific knowledge related to neurotransmitters, the scientific community is now targeting neuronal nicotinic receptors (NNRs), found on nerve cells throughout the central nervous system, to treat a number of psychiatric and neurological disorders. Abbott has opened up a whole new set of possibilities for drug development and biologic treatments that have the potential to more effectively treat individuals with cancer, autoimmune diseases and other complicated conditions. For the third year in a row, Abbott has been named to the Dow Jones Sustainability World Index and the Dow Jones Sustainability North America Index for its continued leadership in business, environmental and social performance. Resources for ... Abbott Worldwide Stock Quote Copyright © 2006, 2008 Abbott Laboratories. Abbott Park, Illinois, U.S.A. Unless otherwise specified, all product names appearing in this Internet site are trademarks owned by or licensed to Abbott Laboratories, its subsidiaries or affiliates. No ...